← Open Payments lookup

IFTEQAR SYED: Open Payments

NPI 1518963081 · PARIS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$448 in 32 payments from 5 companies in 2025. Trend: 2023 $379 · 2024 $306 · 2025 $448

Food & beverage: $448
CompanyPaymentsAmount
Forte Bio-Pharma LLC13$196
ABBVIE INC.15$173
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$37
IDORSIA PHARMACEUTICALS US INC1$21
VERTEX PHARMACEUTICALS INCORPORATED1$20

Products named: PROLATE, UBRELVY, RELISTOR, Quviviq, QULIPTA, JOURNAVX, TANLOR.

Industry payments across TX — which companies pay providers there.